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1. Introduction 
In a previous study [l] we have shown that amino 
acids have inhibitory effects on the synaptosomal 
accumulations of one another. The present study deals 
with the structural requirements of amino acid inhibi- 
tion of Na+-non-dependent synaptosomal amino acid 
transport systems and evaluates the relative roles of 
the length of the side chain, the o-amino group and 
the -COOH group in such inhibition. It is shown that 
while all of the above three are important in regulat- 
ing the inhibitory activity of an amino acid, the 
o-amino group of a neutral side chain is indispensable 
in the interaction of an amino acid with the transport 
site. 
2. Materials and methods 
Uniformly labeled L [i4C]amino acids were 
purchased from New England Nuclear Corp. (Boston, 
MA) and had the following specific radioactivities 
(mCi/mmol): phenylalanine 410; leucine 298; 
valine 22.5. N-acetyl leucine and leucine ethyl ester 
were products of Research Plus Labs (Denville, NJ). 
N-methyl leucine, N-acetyl phenylalanine, phenyl- 
alanine amide, phenylalanine ethyl ester, N-acetyl 
phenylalanine ethyl ester, a-ketoisocaproic acid, 
cu-ketoisovaleric acid and isovaleric acid were 
obtained from Sigma Chemical Co. (St. Louis, MO). 
All other compounds were purchased from Calbiochem 
(San Diego, CA). 
Cerebral cortices obtained from adult Sprague- 
Dawley rats were homogenized in 10 vol. ice-cold 
North-Holland Publishing Company - Amsterdam 
0.32 M sucrose solution. Synaptosomal,fractions 
were prepared from the homogenates by the method 
of Kurokawa et al. [2] and suspended in a buffer 
medium containing 10 mM Tris-HCl, pH 7.4, 15 mM 
MgCls and 300 mM sucrose. Protein concentrations 
of the suspensions were determined by the method 
of Lowry et al. [3]. Portions of the suspensions 
containing 0.1-0.2 mg of synaptosomal protein were 
incubated (25’C, 3 min) with a labeled amino acid 
(0.1 PCi) and various concentrations of unlabeled 
amino acids/amino acid derivatives, in a final volume 
of 1 ml. At the end of the incubation period the 
particles were collected on Millipore filters and 
assayed for radioactivity as described elsewhere [ 1 ] . 
3. Results 
The inhibitory effects of several amino acids on 
the Na’non-dependent synaptosomal uptakes of 
leucine and phenylalanine are summarized in table 1. 
The data show a progressive decrease in the Zse values 
with an increase in the length of the side chain, with 
glycine being the least inhibitory amino acid. 
Several amino acid derivatives that had variations 
in the carboxyl group and in the o-NH1 position were 
tested for their ability to inhibit the influx of 14C- 
labeled phenylalanine, leucine and valine. Results 
obtained with compounds involving alterations of the 
carboxyl group are summarized in table 2. Phenyl- 
alanine amide, phenylalanine ethyl ester and leucine 
ethyl ester at concentrations of 0.5 and 1 mM, sub- 
stantially inhibited the uptakes of the three substrate 
amino acids. The Zse values for these compounds, 
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Table 1 
Inhibition of synaptosomal amino acid uptake by amino acids 
Inhibitor 
Amino acid 
Glycine 
Alanine 
Valine 
lsoleucinc 
Leucine 
Phenylalanine 
Uptake I,, (PM) 
[“Cl Phenylalanine 
1000 + 300 (2) 
90 * 25 (3) 
lo* 2 (IO) 
9-r 1 (6) 
7+ 2 (25) 
(5 f OS] (7) 
[‘“Cl Leucine 
2000 (1) 
235 + 42 (8) 
30+- 5 (7) 
17* 3 (8) 
[9 * 2) (11) 
9* 2 (7) 
Synaptosomal fractions obtained from adult rat brain cortices were incubated 
with 14C-labeled phenylalanine and leucine under conditions described in the text. 
The values for I,, were derived from Hill type plots in which log [(v, -v)/v] (v. is 
the uptake rate in the absence of inhibitor and v the rate in the presence of 
inhibitor at a concentration [Z]) was plotted against log [I]. Values represent 
means f SD and values in parentheses are the number of experiments. 
however, were considerably higher than those for the 
corresponding free amino acids. No significant 
differences could be seen between the inhibitory 
effects of the amide and of the ethyl ester. In contrast, 
when the a-amino group was blocked by a methyl or 
an acetyl group, the inhibitory activity was totally 
lost. Thus, N-acetyl phenylalanine, N-acetyl leucine 
and N-methyl leucine failed to inhibit the uptakes of 
phenylalanine, leucine and valine, even at concentra- 
tions as high as I mM (table 3). Replacement of the 
a-NH2 group with a hydrogen, a keto or a hydroxyl 
group resulted in elimination of inhibitory activity. 
Thus, amino acid uptake was not inhibited by the 
following compounds: phenylpyruvic acid, phenyl- 
acetic acid, phenyllactic acid, a-ketoisocaproic acid, 
a-ketoisovaleric acid and isovaleric acid. As expected 
from the above results, IV-acetyl phenylalanine ethyl 
ester, a compound which has both the carboxyl and 
the a-amino groups blocked, did not inhibit synapto- 
somal amino acid uptake (table 3). 
The importance of a neutral side chain in the 
inhibition is dramatically illustrated by the contrast- 
ing effects of aspartic acid, glutamic acid and lysine 
and their uncharged derivatives on amino acid uptake. 
Table 2 
Effect of modifications of the carboxyl group 
Percent Inhibition of uptake 
Compound Concentration [*Cl Phenylalanine [ “C] Leucine [ “C] Valine 
(mM) 
Phenylalanine amide 0.5 39 40 33 
1.0 55 50 42 
Phenylalanine ethyl ester 0.5 47 37 37 
1.0 63 57 51 
Leucine ethyl ester 0.5 54 35 27 
1.0 66 54 36 
Synaptosomal fractions were incubated with the “C-IabeIed amino acid and the various compounds as 
described in the text. 
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Table 3 
Effect of modifications in the o-amino position 
Percent Inhibition of uptake 
Compound Concentration [ “‘CjPhenylalanine 
(mMI 
[“Cl Leucine [ “C]Valine 
A’-Acetyl phenylalanine 
N-Acetyl phenylalanine 
ethyl ester 
N-Acetyl leucine 
N-Methyl leucine 
Phenylacetic acid 
Phenylpyruvic acid 
Phenyllactic acid 
a-Ketoisocaproic acid 
cr-Ketoisovaleric acid 
Isovalcric acid 
0.5 11 0 7 
1.0 11 0 8 
0.5 0 8 6 
1.0 0 11 6 
0.5 3 4 0 
1.0 6 6 0 
0.5 0 3 0 
1.0 0 8 0 
1.0 0 2 3 
1.0 4 2 0 
1.0 8 1 2 
1.0 2 1 2 
1.0 1 2 0 
1.0 0 0 2 
Synaptosomal fractions were incubated with the “C-labeled amino acids and the various compounds as 
described in the text. 
Table 4 
Neutral side chain requirement for inhibition of amino acid uptake 
Percent Inhibition of uptake 
Compound Concentration 
(mM) 
[ ‘%] Leucine [ “C] Phenylalanine 
Lysine 
Norleucinea 
Aspartic acid 
Asparagine 
Glutamic acid 
Glutamine 
1.0 0 0 
0.02 61 63 
0.1 78 82 
1.0 2 4 
0.1 44 68 
0.5 71 85 
1.0 0 6 
0.1 51 68 
0.5 77 86 
a rJsed in the DL-form 
Synaptosomal fractions were incubated with the ?-labeled amino acids and 
with the various compounds under conditions described in the text. 
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Lysine did not inhibit the uptakes of leucine and 
phenylalanine even at concentrations as high as 1 mM. 
But its uncharged analog, norleucine (in which the 
e-NH2 group is replaced by hydrogen) was highly 
inhibitory (table 4). Similarly, neither aspartic acid 
nor glutamic acid inhibited the uptakes of leucine 
and phenylalanine. However, when the negative 
charges in their side chains were eliminated by intro- 
duction of amide groups in the y and 6 positions, the 
resulting compounds, asparagine and glutamine, 
proved to be strongly inhibitory. Total or near total 
inhibition was observed at 0.5 mM (table 4) and the 
I50 values for inhibition of phenylalanine uptake were 
in the 30 PM range. 
4. Discussion 
The results of the present study clearly indicate 
that while the a-amino group, the carboxyl group and 
the length of the side chain all influence the inhibitory 
activity of an amino acid, the o-amino group plays the 
most significant role in the inhibition. The extent of 
inhibition increased with the length of the side chain. 
Blocking of the -COOH group reduced the affinity of 
the amino acid for the binding site, but did not 
abolish it. However, replacement of the a-amino group 
by hydrogen or by a keto group totally abolished the 
inhibition. Introduction of a methyl group or an acetyl 
group into the amino group also eliminated the 
inhibitory ability of the amino acid suggesting that 
the charge in the o-amino group is not a primary 
requisite for the inhibition. Thus it appears that in the 
interaction of the -NHa group with the transport site 
groups larger than hydrogen cannot be accommodated. 
The requirement of a neutral side chain in the inhibi- 
tion of synaptosomal amino acid uptake is clearly 
illustrated by the results obtained with the derivatives 
of aspartic and glutamic acids and of lysine. These 
results show that compounds with net positive or 
negative charge in their side chains had no inhibitory 
effect on synaptosomal amino acid uptake while 
elimination of the net charge in their molecules 
resulted in strong inhibition. The present studies lead 
to a picture of the amino acid binding site in the 
synaptosomal transport system that is qualitatively 
similar to that suggested by Lin et al. [4] and by 
Hajjar and Curran [5] for the intestinal and the brush 
border transport systems, respectively. They clearly 
show that the a-amino group of the neutral side chain 
is a ‘sine qua non’ in the interaction of a molecule 
with the transport site and that the length of the side 
chain contributes to the binding energy. 
Acknowledgements 
This investigation was supported by a grant from 
the National Institutes of Health, HD-01823. The 
authors wish to acknowledge the excellent technical 
assistance of Sue J. Estey and the valuable suggestions 
of Dr J. Ramachandran, Hormone Research Laboratory, 
University of California, San Francisco, Calif. USA. 
References 
111 
121 
[31 
[41 
[51 
Peterson, N. A. and Raghupathy, E. (1972) J. Neurochem. 
19, 1423-1438. 
Kurokawa, M., Sakamoto, T. and Kato, M. (1965) 
Biochem. J. 97, 833-844. 
Lowry, 0. H., Rosebrough, N. J., Farr, A. L. and 
Randall, R. J. (1951) J. Biol. Chem. 193, 265-275. 
Lin, E. C., Hagihara, H. and Wilson, T. H. (1962) Am. J. 
Physiol. 202, 919-925. 
Hajjar, J. J. and Curran, P. F. (1960) J. Gen. Physiol. 56, 
673-691. 
154 
